On the interactions between nucleotide binding domains and membrane spanning domains in cystic fibrosis transmembrane

Luca Belmonte1, Oscar Moran2

  • 1Istituto di Biofisica, CNR, Genova, Italy; Centre for Integrative Biology, CIBIO, University of Trento, Trento, Italy.

Biochimie
|February 3, 2015
PubMed

Insights

Molecular dynamics simulations reveal how mutations in the Cystic Fibrosis Transmembrane Regulator (CFTR) disrupt nucleotide binding domain interactions, impacting CFTR protein function and leading to cystic fibrosis.

Area of Science:

  • Biophysics
  • Molecular Biology
  • Genetics

Background:

  • Cystic Fibrosis Transmembrane Regulator (CFTR) mutations cause cystic fibrosis.
  • CFTR protein function relies on nucleotide binding domain (NBD) conformational changes upon ATP binding.
  • Key CFTR mutations include ΔF508 (traffic defect) and G551D (gating defect).

Purpose of the Study:

  • Investigate the impact of ΔF508 and G551D mutations on CFTR NBD properties using molecular dynamics.
  • Analyze alterations in NBD1-NBD2 interactions, internal energy, and hydrogen bonding in mutated CFTR.
  • Examine changes in NBDs-ICLs interactions and their potential effect on CFTR channel gating.

Main Methods:

  • Molecular dynamics (MD) simulations.
  • Utilized an homology model of the open channel conformation of CFTR.
  • Introduced ΔF508 and G551D mutations into the CFTR model for analysis.

Main Results:

  • While overall structures are conserved, NBD1-NBD2 interactions are significantly modified in both mutants.
  • ΔF508-CFTR shows destabilized NBDs with higher internal energy and increased NBD1-NBD2 contacts.
  • G551D-CFTR exhibits reduced NBD1-NBD2 contacts and severely reduced hydrogen bonds, with unchanged NBD internal energy.
  • Interactions between NBDs and intracellular loops (ICLs) are altered in both mutants, affecting ATP binding signal transduction.

Conclusions:

  • Single point mutations in CFTR can lead to channel gating defects.
  • Altered interactions within NBDs and between NBDs-ICLs interfaces disrupt ATP-binding and gating mechanisms.
  • These findings provide insights into the molecular basis of cystic fibrosis pathogenesis.

Related Concept Videos

Multi-pass Transmembrane Proteins and β-barrels01:09

Multi-pass Transmembrane Proteins and β-barrels

In multi-pass transmembrane proteins, the polypeptide chain crosses the membrane more than once. The transmembrane polypeptide chain either forms an α-helix or β-strand structure. α-Helix containing multi-pass transmembrane proteins are ubiquitous, whereas β-strand containing ones are mainly found in gram-negative bacteria, mitochondria, and chloroplasts.
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...
6.9K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Mechanisms of Membrane Domain Formation00:59

Mechanisms of Membrane Domain Formation

Different physical properties of lipids and proteins allow them to localize and form distinct islands or domains in the membrane. Some membrane domains are formed due to protein-protein interactions, whereas others are formed due to the presence of specific lipids such as sphingolipids and sterols—for example, large proteins, such as bacteriorhodopsin, aggregate and create distinct domains.
Another mechanism for membrane domain formation involves membrane proteins interacting with...
4.5K